SCOPE: Flavan-3-ols are abundant polyphenols in human nutrition and are associated with beneficial health effects. The aim of this study was to comparatively investigate the metabolic fate of (-)-epicatechin, procyanidin B1, and polymeric procyanidins in a randomized cross-over study in humans. METHODS AND RESULTS: Parent compounds, conjugates, and microbial metabolites were determined in plasma, urine, and faeces by HPLC-MS and GC-MS/MS. Glucuronidated, sulfated, and methylated (-)-epicatechin and 5-(3',4'-dihydroxyphenyl)-valerolactone were the dominant metabolites in blood and urine. In addition, minor amounts of procyanidin B1 and 4-hydroxy-5-(3',4'-dihydroxyphenyl)valeric acid and their conjugated metabolites were detected. The formation of 5-(3',4'-dihydroxyphenyl)-valerolactone and 4-hydroxy-5-(3',4'-dihydroxyphenyl)valeric acid varied largely between individuals as well as with the degree of polymerization of flavan-3-ols. Monomer units were not detectable in plasma or urine after procyanidin B1 and polymeric procyanidin intake. No correlation was found between the intake of flavan-3-ols and the occurrence of phenolic acids in blood and urine or the phenolic compound profiles in faeces. CONCLUSION: In addition to conjugated metabolites derived from the absorption of monomeric flavan-3-ols, 5-(3',4'-dihydroxyphenyl)-valerolactone represents an important in vivo metabolite of (-)-epicatechin and procyanidin B1 produced by the gut microbiota.
RCT Entities:
SCOPE: Flavan-3-ols are abundant polyphenols in human nutrition and are associated with beneficial health effects. The aim of this study was to comparatively investigate the metabolic fate of (-)-epicatechin, procyanidin B1, and polymeric procyanidins in a randomized cross-over study in humans. METHODS AND RESULTS: Parent compounds, conjugates, and microbial metabolites were determined in plasma, urine, and faeces by HPLC-MS and GC-MS/MS. Glucuronidated, sulfated, and methylated (-)-epicatechin and 5-(3',4'-dihydroxyphenyl)-valerolactone were the dominant metabolites in blood and urine. In addition, minor amounts of procyanidin B1 and 4-hydroxy-5-(3',4'-dihydroxyphenyl)valeric acid and their conjugated metabolites were detected. The formation of 5-(3',4'-dihydroxyphenyl)-valerolactone and 4-hydroxy-5-(3',4'-dihydroxyphenyl)valeric acid varied largely between individuals as well as with the degree of polymerization of flavan-3-ols. Monomer units were not detectable in plasma or urine after procyanidin B1 and polymeric procyanidin intake. No correlation was found between the intake of flavan-3-ols and the occurrence of phenolic acids in blood and urine or the phenolic compound profiles in faeces. CONCLUSION: In addition to conjugated metabolites derived from the absorption of monomeric flavan-3-ols, 5-(3',4'-dihydroxyphenyl)-valerolactone represents an important in vivo metabolite of (-)-epicatechin and procyanidin B1 produced by the gut microbiota.
Authors: Benjamin F Bitner; Jason D Ray; Kyle B Kener; Jacob A Herring; Josie A Tueller; Deborah K Johnson; Claudia M Tellez Freitas; Dane W Fausnacht; Mitchell E Allen; Alexander H Thomson; K Scott Weber; Ryan P McMillan; Matthew W Hulver; David A Brown; Jeffery S Tessem; Andrew P Neilson Journal: J Nutr Biochem Date: 2018-09-15 Impact factor: 6.048
Authors: Heike Asseburg; Carmina Schäfer; Madeleine Müller; Stephanie Hagl; Maximilian Pohland; Dirk Berressem; Marta Borchiellini; Christina Plank; Gunter P Eckert Journal: Neuromolecular Med Date: 2016-07-25 Impact factor: 3.843
Authors: Jessica L di Gesso; Jason S Kerr; Qingzhi Zhang; Saki Raheem; Sai Krishna Yalamanchili; David O'Hagan; Colin D Kay; Maria A O'Connell Journal: Mol Nutr Food Res Date: 2015-05-03 Impact factor: 5.914
Authors: Richard Draijer; Ferdi A van Dorsten; Yvonne E Zebregs; Boudewijn Hollebrands; Sonja Peters; Guus S Duchateau; Christian H Grün Journal: Nutrients Date: 2016-12-15 Impact factor: 5.717
Authors: Anallely López-Yerena; Inés Domínguez-López; Anna Vallverdú-Queralt; Maria Pérez; Olga Jáuregui; Elvira Escribano-Ferrer; Rosa M Lamuela-Raventós Journal: Antioxidants (Basel) Date: 2021-05-25